# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
CRNX: 11% | Crinetics Pharmaceuticals shares are trading higher after the company announced the early release of ENDO 2024 late...
BuzzFeed shares surged after Vivek Ramaswamy acquired a 7.7% stake for $3.2 million.
BuzzFeed (NASDAQ:BZFD) reported quarterly losses of $(0.72) per share. This is a 13.25 percent increase over losses of $(0.83) ...